iStar Medical announced today that it expanded the commercial rollout of its MINIject device with the first implants in Ireland.
MINIject, a minimally invasive glaucoma surgery (MIGS) device, treats open-angle glaucoma. Currently the only commercially available supraciliary MIGS implant, it has demonstrated meaningful and sustained performance, plus a favorable safety profile.
The device combines the porous structure of iStar’s proprietary STAR material with the power offered by the supraciliary space to enhance natural fluid outflow, reduce intraocular pressure and the need for medication while bio-integrating with surrounding tissue, limiting inflammation, fibrosis and subsequent complications.
Get the full story at our sister site, Drug Delivery Business News.